Actinium Pharmaceuticals is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Sandesh C. Seth, with a market cap of $35.8M.
Common questions about Actinium Pharmaceuticals
Actinium Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 8, 2026.
Actinium Pharmaceuticals has approximately 49 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.